18th Annual International Congress on Hematologic Malignancies®
Crowne Plaza
New York, NY
February 14 - 15, 2014
31st Annual Miami Breast Cancer Conference®
Fontainebleau Miami Beach
Miami Beach, FL
March 6 - 9, 2014
7th Annual Interdisciplinary Prostate Cancer Congress™ (IPCC®)
Corwne Plaza 
New York, NY
March 15, 2014
13th Annual International Congress on the Future of Breast Cancer®
Hyatt Regency
Huntington Beach, CA
July 17 - 19, 2014
15th Annual International Lung Cancer Congress®
Hyatt Regency
Huntington Beach, CA
July 31 - August 2, 2014

12th Annual International Congress on Targeted Therapies in Cancer®
New York, NY
October 2014

12th Annual School of Breast Oncology®
Emory University Conference Center
Atlanta, GA

November 6 - 9, 2014

9th Annual New York Lung Cancer Symposium®
New York
November 8, 2014

Upcoming AJMC events
With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Sarah J. Lorance Highlights Findings of Recent Medicare Audits
The most recent Medicare Advantage and Part D program audits revealed that oversight of formulary administration is an area that health plans continue to struggle with, Sarah J. Lorance, vice president of Medicare Compliance at WellPoint, said at America’s Health Insurance Plans’ National Conference on Medicare and Medicaid and Dual Eligibles Summit in Washington, DC.
ASCO President Dr Peter Yu Discusses Aggregating Patient, Doctor Data
The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president.
Dr Jan Berger Says Genetic Testing
Genetic and companion testing takes a village, according to Jan Berger, MD, MJ, president and chief executive officer of Health Intelligence Partners and editor-in-chief of The American Journal of Pharmacy Benefits.
Episode 16 - Closing Remarks
As the panel discussion concludes, Peter Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Yehuda Handelsman, MD, FACP, FACE, FNLA; Maria Lopes, MD, MS; and Kari Uusinarkaus, MD, FAAFP, FNLA, share their final insights about managed care models and clinical and economic outcomes in diabetes and obesity.